Neuroleptic malignant syndrome caused by dopamine depleting drugs.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D011954:Receptors, Dopamine / Q000187:drug effects*; D013747:Tetrabenazine / Q000009:adverse effects
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D004298:Dopamine; D013747:Tetrabenazine